Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm	Active, not recruiting	Not applicable	2026-06-03		NCT02450708

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Center for International Blood and Marrow Transplant Research	16
Dana-Farber Cancer Institute	324
Duke University	446
H. Lee Moffitt Cancer Center and Research Institute	162
Hackensack Meridian Health	52
M.D. Anderson Cancer Center	1145
Mayo Clinic	970
Memorial Sloan Kettering Cancer Center	753
University of Washington	397

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baylor University Medical Center	Dallas	United States	87
Dana Farber Cancer Institute	Boston	United States	133
Duke University Medical Center	Durham	United States	4
Hackensack University Medical Center Cancer Center	Hackensack	United States	1
Mayo Clinic Cancer Center	Rochester	United States	16
MD Anderson Cancer Center	Houston	United States	589
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Moffitt Cancer Center	Tampa	United States	523
Ohio State University	Columbus	United States	169
University of Washington School of Medicine	Seattle	United States	4